Systems and methods for providing drug prescription information with monitored cardiac information
Inventors
Sipe, Michael A. • Volosin, Kent
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-12465212-B2
Publication Date
2025-11-11
Expiration Date
Abstract
A system for providing electrocardiogram (ECG) information to a healthcare provider (HCP) is provided. The system includes a network interface configured to receive drug prescription information from a computing device associated with the HCP and ECG data from a medical device associated with a patient. The system also includes a memory configured to store the drug prescription information and the ECG data. The system can further a processor configured to select a period of time over which to review the received drug prescription information and the received ECG data, retrieve the received ECG data for the selected period of time, derive one or more ECG metrics including at least one heart rate parameter, and generate a graphical representation indicating a trend in the one or more ECG metrics and a relationship between the one or more ECG metrics and the drug prescription information.
Core Innovation
The invention provides patient alert information to a healthcare provider using a wearable medical device configured to monitor electrocardiogram information and a remote server processor operably coupled to the wearable medical device. The remote server processor receives the ECG information, initial drug prescription information including identification of a drug administered to the patient and a first dosage for the drug, HCP-controlled heart rate control criteria, and one or more predetermined cardiac event parameters.
The remote server processor monitors the ECG information for heart rate control events during a duration of time over which daily maximum heart rate threshold value and nighttime heart rate threshold value are applied. Each heart rate control event is a transgression of either threshold during the duration of time, and based on the heart rate control criteria the remote server processor determines that the heart rate status of the patient is not under control in accordance with a predetermined guideline directed medical treatment for the patient.
In response to the determination that the heart rate status is not under control, the remote server processor provides an informational alert to the healthcare provider. The informational alert includes at least one recommended change to the initial drug prescription information, including at least a recommended updated dosage to the drug, and the system also receives updated drug prescription information including a second dosage and provides a graphical representation indicating information on heart rate control events within the duration of time.
The graphical representation includes a first monitoring period for the initial drug prescription and a second monitoring period for the updated drug prescription, along with an average daily heart rate derived from the ECG information.
Claims Coverage
The document includes two independent claims: a system claim and a method claim. Across the independent claims, three inventive features are recited: HCP-controlled threshold-based heart-rate control events, determination that heart rate status is not under control, and an HCP informational alert with graphical representation linked to initial and updated monitoring periods.
HCP-controlled threshold-based heart-rate control events
Heart rate control criteria including a daily maximum heart rate threshold value, a nighttime heart rate threshold value, and a duration of time over which the thresholds are applied, wherein heart rate control events are transgressions of either threshold during the duration of time.
Determination of not under control based on transgression criteria
Monitoring the ECG information for one or more heart rate control events during the duration of time and determining, based on the heart rate control criteria, that the heart rate status of the patient is not under control in accordance with a predetermined guideline directed medical treatment for the patient.
HCP informational alert with recommended updated dosage
In response to the determination that the heart rate status of the patient is not under control, providing an informational alert to the HCP comprising at least one recommended change to the initial drug prescription information, including at least a recommended updated dosage to the drug administered to the patient.
Graphical representation linked to initial and updated monitoring periods
Providing a graphical representation indicating information on at least one of the heart rate control events occurring within the duration of time, with a first monitoring period during which the drug is administered in accordance with the initial drug prescription information and a second monitoring period during which the drug is administered in accordance with the updated drug prescription information, including an average daily heart rate derived from the ECG information.
The independent claims collectively cover wearable ECG monitoring with HCP-configurable heart-rate control criteria, transgression-based determination of not under control, HCP informational alerts with recommended updated drug dosage, and graphical representations distinguishing initial and updated monitoring periods while showing heart-rate control events and average daily heart rate.
Stated Advantages
Documented Applications
No documented applications found
Interested in licensing this patent?